Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling study

Abstract

SUMMARYObjectives Paracetamol is the most commonly administered medicine to children. A recent study highlighted the risk of overdose of paracetamol using British National Formulary for Children (BNFC) age-based dosing guidelines. This current study assesses the safety of changes to the UK paracetamol product dosing system proposed by the Medicines and Healthcare products Regulatory Authority (MHRA) which include a larger number of narrower age bands and a single dose per age band.Design Theoretical comparison of the proposed MHRA dosing system with the product dosing instructions of a commonly prescribed form of paracetamol in the UK. Setting United KingdomParticipants Proposed MHRA dosing recommendations and current product dosing instructions were compared using a previously validated model.Main outcome measures For both dosing recommendations, single and cumulative daily doses of paracetamol for boys and girls at the 9th, 50th and 91st centiles for weight were calculated for 3 month, 1 year, 6 year and 12 year age groups.Results With the current product dosing instructions, underweight children are at risk of receiving approximately two times the recommended single and cumulative daily dose of paracetamol, particularly at age 1 year and 6 years. This risk is negligible when the same model is applied to the proposed MHRA dosing system, whereby underweight, average weight and overweight children at all ages receive doses marginally above or within the recommended dose range or limit. ConclusionThe proposed MHRA dosing recommendations for paracetamol use in children are effective at reducing the risk of paracetamol overdose in children of all ages, when compared with current product dosing instructions. DECLARATIONS Competing interestsNone declared

A clinical and safety review of paracetamol and ibuprofen in children

“…In addition, a recent UK study found that, even when administered under current instructions, underweight children are at risk of receiving approximately twice, and average weight children up to 133% of, the recommended single and cumulative daily dose of paracetamol; this has led to recently proposed changes in dosing recommendations (Eyers et al 2012a , b ). Two reports of hepatotoxicity in association with dosages reported to be in the therapeutic range (Heubi et al 1998 ; Makin et al 1995 ) may represent inaccurate memory of the administered doses or a narrower paracetamol therapeutic window because of associated conditions.…”

Pediatric Groin Surgeries

“…Thereafter, the oral paracetamol was continued 6 hourly for 72 hours. [ 8 ] The researcher contacted the parents/caregivers 6 hours after discharged from hospital via mobile phone to know the pain scores and time the first dose of analgesia was administered to the patients at home. The parents/caregivers were duly informed to record the pain scores in the FLACC score sheet and they brought the FLACC score sheet to the outpatient clinic.…”

A Practical Approach to the Treatment of Low-Risk Childhood Fever

“…Current UK dosing guidelines are age-based (Table 4 ). However, a recent UK study found that underweight children are at risk of receiving approximately 200 %, and average-weight children up to 133 % of the recommended single and cumulative daily dose of paracetamol, leading to recently proposed changes in dosing recommendations [ 71 , 72 ]. To reduce the risk of overdosing or underdosing, dosing guidelines in some other countries are based on weight or both age and weight; the typical recommendation for ibuprofen is 5–10 mg/kg per dose, while for paracetamol it is 10–15 mg/kg per dose [ 1 , 22 , 73 ].…”